Ixekizumab monoclonal antibody drug. Targets interleukin 17 (IL-17); indicated for treatment of plaque psoriasis. Generic name and stylized antibody.

---

Size: 9000px × 4926px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: 17, antibody, autoimmune, biological, biosimilar, biotech, biotechnology, cytokine, disease, drug, il-17, il-17a, immunoglobulin, immunology, inflammation, infusion, injection, inn, interleukin, ixekizumab, mab, monoclonal, nomenclature, pasi, peptide, plaque, protein, psoriasis